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Abstract
Herpes simplex virus 1 (HSV-1) establishes life-long latent infection within sensory neurons,
during which viral lytic gene expression is silenced. The only highly expressed viral gene
product during latent infection is the latency-associated transcript (LAT), a non-protein cod-
ing RNA that has been strongly implicated in the epigenetic regulation of HSV-1 gene
expression. We have investigated LAT-mediated control of latent gene expression using
chromatin immunoprecipitation analyses and LAT-negative viruses engineered to express
firefly luciferase or β-galactosidase from a heterologous lytic promoter. Whilst we were
unable to determine a significant effect of LAT expression upon heterochromatin enrich-
ment on latent HSV-1 genomes, we show that reporter gene expression from latent HSV-1
genomes occurs at a greater frequency in the absence of LAT. Furthermore, using lucifer-
ase reporter viruses we have observed that HSV-1 gene expression decreases during long-
term latent infection, with a most marked effect during LAT-negative virus infection. Finally,
using a fluorescent mouse model of infection to isolate and culture single latently infected
neurons, we also show that reactivation occurs at a greater frequency from cultures har-
bouring LAT-negative HSV-1. Together, our data suggest that the HSV-1 LAT RNA
represses HSV-1 gene expression in small populations of neurons within the mouse TG, a
phenomenon that directly impacts upon the frequency of reactivation and the maintenance
of the transcriptionally active latent reservoir.
Author Summary
Like all herpesviruses, herpes simplex virus 1 (HSV-1) persistently infects an individual
for their entire life. This persistent—or latent—virus is maintained as silenced DNA within
the nuclei of sensory neurons, from which only the virus latency-associated transcript
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RNA is abundantly transcribed. Periodically, within an individual neuron, this silencing
may be reversed and HSV-1 can reactivate to full virus replication. In this study we assess
the role of the HSV-1 latency-associated transcript in the control of viral genome silencing
and reactivation in mouse nervous tissue and individual neurons. We show that the
latency-associated transcript decreases the expression of reporter genes engineered into
the HSV-1 genome, as well as reducing the frequency of reactivation from individual neu-
rons. Our study shows that in a proportion of latently-infected neurons, HSV-1 actively
reduces the frequency of reactivation to full lytic replication. Such a function may increase
the longevity of the infected neuron population within the infected individual, increasing
the potential for life-long transmission to new hosts.
Introduction
Herpes simplex viruses 1 (HSV-1) and 2 (HSV-2) are ancient human pathogens that are most
commonly associated with sub-clinical and mild infections but can occasionally cause severe
life threatening disease [1]. HSV-1 is most commonly associated with infection of the oral
mucosa, and following productive primary infection at this site the virus is able to access the
sensory neurons of the trigeminal ganglia (TG). Within these cells, HSV is able to establish a
latent infection, characterised by a global reduction of lytic gene expression and an absence of
infectious virus production. Periodically, latency is interrupted by reactivation of virion pro-
duction from latent viral DNA, allowing for the transmission of the virus to new hosts. During
latency, viral gene expression is largely restricted to the latency-associated transcript (LAT).
The LAT is an 8.3kb primary transcript, which is spliced into stable 1.5 and 2 kb major LAT
introns, as well as a 6.3 kb minor LAT exon that is processed into a number of microRNAs.
The HSV LAT and its associated microRNA species appear to limit HSV immediate-early (IE)
gene expression in vitro [2–4], as well as limiting the accumulation of viral lytic gene transcripts
during acute and latent infection of mouse models [5, 6]. The LAT intron has also been
strongly implicated in the global control of latent HSV gene expression in a number of studies
describing the post-translational modification (PTM) of histones associated with viral promot-
ers [7–11].
Using a reporter mouse model of infection, we have previously described a role for the LAT
RNAs in maintaining the latently infected cell reservoir in the TG [12]. During infection with
LAT-negative recombinants, latently infected neurons were lost at a rate of 1.7 neurons per TG
per day. In contrast latent cell numbers remained stable up to 140 days post-infection with
LAT-positive virus [12]. An additional study also identified a role for LAT in maintaining HSV
reactivation competence following latent infection of the mouse TG [13]. Together, these
reports suggest that the LAT RNAs enhance infected cell survival throughout latency and may
do so by limiting reactivation of the virus from latency. In this study we have sought to deter-
mine whether LAT expression maintains the repression of the latent HSV genome in vivo by
engineering a deletion of the LAT promoter into a previously characterised HSV-1 recombi-
nant that expresses firefly luciferase [14]. With firefly luciferase under the control of the
human cytomegalovirus (HCMV) major immediate early promoter (MIEP) (which is strongly
expressed in neurons and whose activity does not require prior HSV lytic gene production),
these viruses allow for a model of infection in which de-repression of the latent virus genome
can be quantified directly from infected tissues. Using this approach to quantify both reporter
gene expression and viral DNA loads within individual TGs, we have observed up to 4.9-fold
greater median luciferase signal from LAT-negative mutants during latent infection in mouse
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TGs. We further identified that this increased gene expression is likely due to an increase in the
number of cells in which virus gene expression occurs, and that reactivation frequency from
individual latently infected neurons in ex vivo culture is also increased during LAT-negative
HSV-1 infection. Finally, we demonstrate that in the absence of LAT expression, a significant
and more prominent loss of luciferase signal relative to wildtype virus can be observed follow-
ing long-term latent infection. Together, these data show that LAT represses gene expression
from the virus genome as well as full productive reactivation.
Results
In vitro and in vivo characterisation of HSV-1 firefly luciferase
recombinants with deletion and rescue of the LAT promoter
To investigate the role of LAT expression upon regulation of HSV-1 genome silencing, firefly
luciferase-expressing viruses carrying deletions of the LAT promoter (LAP) were constructed
on an HSV-1 strain SC16 genomic background, as described in Materials and Methods. Briefly,
all viruses harbour an HCMVMIEP firefly luciferase expression cassette inserted in place of
the viral US5 gene. The independently generated LAT-deletion mutants harbour an HCMV
MIEP GFP expression cassette (a 1369bp NsiI-PstI fragment from pEGFP-C1; Clontech) in
place of the 203bp core LAT promoter, inserted in the opposite orientation to the LAT gene.
The rationale for these recombinants was to engineer a sensitive quantifiable reporter gene
under the control of the HCMVMIEP into HSV-1, a promoter which has a) strong neuronal
activity [15, 16], b) is suppressed during HSV-1 latency [15] and c) as a heterologous promoter
is not dependent on HSV-1 gene products for its activation [17]. De-repression of gene expres-
sion from the HSV-1 genome should thus allow for strong expression of the reporter gene.
The predicted genomic structures (Fig 1A) were confirmed by Southern blot hybridisation
(Fig 1B).
Most notably, following PstI digest the 203bp LAP DNA fragment was present in
SC16CMVluc and SC16CMVlucREV but absent from independent SC16CMVlucΔLAT-GFP
recombinants 1 and 2. Insertion of the HCMV-MIEP GFP expression cassette into the LAP
locus was further confirmed by a shift from the 7.5 kb PstI restriction DNA fragment observed
in wildtype and revertant viruses to a 9.1 kb fragment in both independent LAT-negative
viruses (Fig 1B). Quantitative reverse transcription PCR (qRT-PCR) analysis of RNA from
TGs of mice latently infected with SC16CMVluc, SC16CMVlucREV and SC16CMVluc-
ΔLAT-GFP recombinants 1 and 2 demonstrated a 5000-to-7500-fold reduction in major LAT
expression from the LAT-negative mutants (Fig 1C), a similar or greater reduction in expres-
sion observed for LAT-deletion mutants described elsewhere [7, 10, 12]. All luciferase recombi-
nants replicated with highly similar kinetics and in a manner indistinguishable to wildtype
SC16 in a multi-step growth curve (Fig 1D). Furthermore, luciferase expression was equivalent
from all viruses during infection in cell culture (Fig 1E). To assess virus replication in vivo,
C57BL/6 mice were infected with SC16CMVluc, SC16CMVlucREV and SC16CMVluc-
ΔLAT-GFP recombinants 1 and 2 (as detailed in Materials and Methods) and infectious virus
titres were determined for whisker pad and TG tissues four days post-infection (d.p.i.). By
comparison with the previously characterised SC16CMVluc recombinant [14] average titres
were similar between all recombinants in both the whisker pads and TGs (Fig 2A and 2B).
No significant difference in virus titres was ascertained from the whisker pads or TGs
(P = 0.1 and 0.2, respectively; one-way analysis of variance, n = 8 mice per virus). To further
scrutinise virus kinetics in vivo, mice were inoculated as before but assessed by live luciferase
imaging (Fig 2C), which allows for repeated analysis of the same mice throughout infection.
Infection kinetics of all four viruses was highly similar in the mouse whisker pads (Fig 2D). In
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an independent experiment, similar luciferase expression kinetics were also observed in the dis-
sected TG of mice during acute infection with each virus, using a 96-well plate luminometer
(Fig 2E).
Fig 1. Generation of luciferase reporter viruses bearing deletions of the core LAT promoter. a) Genomic structures of SC16CMVluc and
SC16CMVlucREV (LAT-positive recombinants), and SC16CMVlucΔLAT-GFP-1 and SC16CMVlucΔLAT-GFP-2 (LAT-negative recombinants). All four
viruses harbour an HCMVMIEP-firefly luciferase expression cassette within the non-essential HSV-1 US5 locus. b) Genomic structures as analyzed by
Southern blot hybridization. Restriction digest with PstI demonstrated all predicted restriction fragments, including the 203 bp LAT promoter. The 3.3-kbHpaI
fragment encoded within pPSTD1 was utilized as a probe. c) LAT expression was quantified by qRT-PCR from total TG cDNA. Primers for the major LAT
intron and cyclophilin RNA were used. Histograms represent the mean (± SEM) numbers of major LAT RNA copies per 105 copies of cyclophilin RNA from
triplicate PCRs. d) Low (0.01) moi in vitro growth curves of recombinant viruses and wildtype strain performed in BHK cells. e) Firefly luciferase reporter
viruses express equivalent levels of luciferase during infection in vitro. BHK cells were infected at an moi of 0.1 and harvested for luciferase assay at 3, 4, 8,
24, 31 and 49 hours post-infection. Symbols represent mean luciferase activity from three biological replicates. Error bars represent SEM.
doi:10.1371/journal.ppat.1005539.g001
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In the absence of LAT transcription, HSV-1 recombinants express
elevated levels of luciferase during neuronal latency
We have previously reported that LAT expression leads to stable maintenance of infected cell
populations throughout long-term latent infection [12], indicating that the LAT RNAs facili-
tate survival of latently infected neurons over protracted time periods. One explanation for this
phenomenon could be an increased frequency of lytic gene expression during latency (poten-
tially proceeding to infectious virus production), followed by cell death.
To observe the earliest stages of virus reactivation (measured by CMV promoter de-repres-
sion and induction of luciferase gene expression from the latent HSV genome) we infected 24
C57BL/6 mice with SC16CMVluc, SC16CMVlucREV and SC16CMVlucΔLAT-GFP recombi-
nants 1 and 2 for TG luciferase imaging. This methodology allows for the direct measurement
of luciferase activity and thus de-repression of latent virus genomes within intact TGs dissected
30 days p.i (Fig 3A). Following capture of luciferase signal, total DNA was extracted from each
individual TG in order to normalise signal intensity to virus loads (Fig 3B). A statistically sig-
nificant increase in luciferase signal was observed following establishment of latency with both
LAT-negative mutants, which was 2.1–4.9-fold higher relative to the wildtype and revertant
Fig 2. Luciferase reporter virus characterisation in vivo. a) Virus titres obtained from the whisker pads of C57BL/6, 4 dpi. Each symbol represents titres
from an individual mouse and the floating bar represents the mean. b) Virus titres obtained from pairs of TG of C57BL/6, 4 dpi. Each symbol represents titres
from an individual mouse and the floating bar represents the mean. c) Representative image of luciferase signal (colourimetric overlay) in live mice 2 days
post-infection. d) Luciferase signal observed from reporter virus infection of C57BL/6 animals during acute infection. Each symbol represents mean
luciferase signal (± SEM) (n = 4 mice 2 dpi, n = 7–8 on days 4–8 post infection). e) Luciferase signal observed from dissected TG homogenates during acute
infection. Each symbol represents mean luciferase signal (± SEM) (n = 8 individual TGs).
doi:10.1371/journal.ppat.1005539.g002
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recombinants (Fig 3B). Similar luciferase signals were recorded from both LAT-negative virus
infections, and SC16CMVlucREV possessed an insignificant yet slightly lower median signal in
comparison to SC16CMVluc (P = 0.34 and 0.17, respectively; Kruskal-Wallis with Mann-
Whitney post-tests).
The elevation in luciferase signal from LAT-negative viruses was corroborated in a repeat
experiment measuring TG pairs (S1 Fig). Together these data demonstrate enhanced expres-
sion of an exogenous reporter gene in the absence of LAT expression, consistent with a relaxa-
tion of global gene silencing during latency.
Chromatin immunoprecipitation analysis of the latent HSV-1 genome
Previous investigations have strongly indicated a role for LAT expression (and the major LAT
intron, in particular) in the epigenetic regulation of HSV-1 gene expression [7–10]. In order to
examine the contribution of chromatin regulation on the observed luciferase expression phe-
notype in our experiments, as well as assessing the level of epigenetic repression upon endoge-
nous HSV-1 promoters, we next sought to determine the enrichment of both activating and
repressive modified histones by chromatin immunoprecipitation analysis. To investigate this,
we utilised polyclonal antibodies specific to pan-acetylated histone protein 3 (H3ac: a marker
of activating euchromatin) and trimethylated lysine 27 of histone protein 3 (H3K27me3: a
Fig 3. Luciferase expression is higher during LAT-negative HSV-1 infection in latent trigeminal ganglia. a) Following injection of D-luciferin substrate,
TGs were dissected at set times from each mouse and luciferase intensity was measured. Displayed are composite photographs of dissected TGs with
luciferase signal represented by a colourimetric overlay. The luciferase signal overlay is relative to the displayed scale. b) Luciferase signal was quantified
with Living Image software and normalised to relative HSV-1 DNA loads within the same TGs. Each symbol represents normalised luciferase signal from an
individual TG. Floating bars represent the median signal of each virus group. A signal of 1x104 ps-1cm-2sr-1 represents a background threshold of detection.
Statistically significant differences were observed between LAT-positive and LAT-negative viruses, with the exception of SC16CMVlucΔLAT-GFP-1 vs
SC16CMVluc (SC16CMVlucΔLAT-GFP-1: P = 0.09 and 0.007 compared to SC16CMVluc and SC16CMVlucREV, respectively; SC16CMVlucΔLAT-GFP-2:
P = 0.04 and 0.0002 compared to SC16CMVluc and SC16CMVlucREV, respectively; Kruskal-Wallis with Mann-Whitney post-tests).
doi:10.1371/journal.ppat.1005539.g003
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marker of repressive facultative heterochromatin). We confirmed the specificity of these anti-
bodies within mouse TGs by specifically immunoprecipitating known euchromatic and hetero-
chromatin regions of the mouse genome [adenine phosphoribosyltransferase: APRT and an
upstream region of gene hoxa5 [8]] with H3ac and H3K27me3 antibodies, respectively (Fig 4A
and 4B).
Forty-eight C57BL/6 mice were infected with 106 pfu of SC16CMVluc, SC16CMVluc-
ΔLAT-GFP-1, SC16CMVlucΔLAT-GFP-2 or SC16CMVlucREV. Chromatin was isolated 30
dpi from the TGs of three pooled mice per virus, as described in Materials and Methods. Four
biological repeats per virus were conducted in total. To assess the global regulation of the HSV-
1 genome we measured histone enrichment upon the endogenous VP16 and ICP0 promoters,
as well as a region of the LAT enhancer. As three HCMVMIEP promoters are present in both
LAT-negative viruses, we assessed chromatin enrichment upon the very 5' coding sequence of
the firefly luciferase cassette. We observed negligible levels of pan-acetylated H3 enrichment
on these sequences, with all consistently less enriched than the facultative heterochromatin
control sequence of uphoxa5 (S2A Fig). We also failed to detect any immunoprecipitated H3ac
Fig 4. Latent HSV-1 genomes are highly enriched in facultative heterochromatin.Chromatin aliquots
isolated from latently infected mouse TGwere precipitated with antibodies to H3ac or H3K27me3. The specificity
of each antibody was assessed by quantifying the relative enrichment of sequences known to be associated
with euchromatin (APRT) or facultative heterochromatin (upHoxa5). Symbols represent percentage enrichment
of sequences from individual TGs (n = 16) and floating bars represent themeans of these data following
immunoprecipitation with a) anti-H3ac and b) anti-H3K27me3 antibodies. c) Fold enrichment of four virus
sequences with facultative heterochromatin marker H3K27me3. Histogram displays the average of four
independent experiments (+ SEM), each comprising groups of three pooled TGs per virus. Fold enrichment of
H3K27me3 immunoprecipitation (IP) was calculated as: [Virus sequence IP (IP + Input)] [cellular APRT IP
 (IP + Input)].
doi:10.1371/journal.ppat.1005539.g004
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in a number of PCRs (S1 Dataset). A notable enrichment of H3ac was detected on the LAT
enhancer in only one of four biological repeats from a single virus (S2B Fig). In contrast, recip-
rocal analysis with H3K27me3 demonstrated that all four target regions were highly enriched
with facultative heterochromatin (Fig 4C). These data confirm that the vast majority of HSV-1
genomes are indeed highly repressed during latency. More surprisingly, we were unable to
determine a statistically significant difference in H3K27me3 enrichment between LAT-positive
and LAT-negative viruses at any of the examined regions of the genome, in contrast with previ-
ous reports [8, 10]. However, our data do suggest a minor reduction in H3K27me3 enrichment
upon both firefly luciferase and the LAT enhancer during LAT-negative virus infection (Fig
4C). To functionally examine whether these reductions could be explained by the insertion of
HCMVMIEP into the LAT locus rather than by an absence of LAT expression, HSV-1 micro-
RNA and reporter gene transcription were determined from mouse TGs latently infected with
previously characterised HSV-1 recombinants SC16CMVCre, SC16CMVCreΔLAT-GFP and
SC16CMVCreΔLAT [12]. QRT-PCR analysis showed no significant difference in the transcrip-
tion of four HSV LAT-associated microRNAs or a Cre recombinase reporter gene between the
LAT-negative viruses (S3 Fig), despite the absence of a LAT-associated HCMVMIEP in
recombinant SC16CMVCreΔLAT. These data suggest that the HCMVMIEP was not responsi-
ble for our observations during LAT-negative luciferase virus infection.
The frequency of reporter gene positive neurons is increased during
latency with LAT-negative HSV-1 recombinants
Our data demonstrate that LAT-negative HSV-1 recombinants express up to 4.9-fold greater
levels of firefly luciferase relative to LAT-positive HSV-1. Whilst ChIP analyses could not show
a significant difference in H3K27me3 enrichment between all four viruses, the small reduction
in this repressive chromatin marker with independent LAT-negative recombinants suggests
that only a minority of genomes within TG are de-repressed in the absence of LAT expression.
Thus, luciferase expression may simply be greater because it occurs in a greater number of cells
at any one time during LAT-negative virus infection. In order to assess the frequency of
reporter gene positive neurons, mice were infected with LAT-negative (SC16CMVlacZ-
ΔLAT-GFP) and revertant (SC16CMVlacZREV) reporter viruses, which contain an HCMV
MIEP lacZ cassette inserted into the US5 locus of the HSV-1 genome (Fig 5A and S4 Fig).
The rationale for this approach was to generate viruses expressing a reporter gene from the
HSV-1 genome that would allow for the identification of single cells in dissected tissues. As
lacZ is encoded within HSV-1 its expression is therefore indicative of a de-repressed and tran-
scriptionally active virus genome. During acute infection, both of these viruses replicated to
comparable titres in C57BL/6 mice infected with 106 pfu per whisker pad (Fig 5B: N = 5 mice
per virus per time-point). QRT-PCR analysis of RNA from TGs of mice latently infected (30
dpi) with both viruses demonstrated a 400-fold reduction in major LAT expression from the
LAT-negative mutant SC16CMVlacZΔLAT-GFP (Fig 5C: N = 5 mice per virus). During
latency (32 dpi), TG were dissected, incubated in Xgal to detect lacZ expression from HSV-1
genomes (Fig 5D) and β-gal-positive cells enumerated. SC16CMVlacZΔLAT-GFP-infected
TGs contained 7.9x as many positive cells as the SC16CMVlacZREV revertant virus (P =
<0.0005, Student's t-test) with an average (± SEM) of 12.6 ± 2.5 and 1.6 ± 0.5 β-gal-positive
cells per TG, respectively (Fig 5E). SC16CMVlacZΔLAT-GFP-infected mouse TG contained
1.3x as much HSV-1 DNA as SC16CMVlacZREV (Fig 5F). This difference was not significant
(P = 0.43; Student's t-test) and cannot account for the 7.9x increase in β-gal-positive cells in the
absence of LAT expression during latency. An increased frequency of β-gal-positive cells dur-
ing SC16CMVlacZΔLAT-GFP infection was also determined relative to a wildtype HSV-1
LAT Represses Latent HSV-1 Gene Expression
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recombinant harbouring the same HCMVMIEP-lacZ expression cassette (S4C Fig). Whilst it
is possible that post-transcriptional down-regulation of lacZ expression by the LAT intron or
LAT microRNAs may be responsible for these data, taken together with our observations dur-
ing luciferase virus infection, we interpret these data to suggest that in the absence of LAT
expression, genome de-repression occurs at a higher frequency than wildtype virus.
Reporter gene expression decreases with time and is most pronounced
during LAT-negative HSV-1 latency
We have previously reported that infected cell numbers decrease during long-term latent infec-
tion with LAT-negative HSV-1 recombinants [12]. We hypothesised that this loss of cells may
be a consequence of reactivating neurons, and would thus include the minority population
undergoing viral transcription during latency. If so, we would anticipate that viral gene expres-
sion would decrease with time in the absence of LAT expression. To test this possibility, we
assessed normalised luciferase signal from latent TGs dissected 120 dpi. These TGs were dis-
sected from 24 C57BL/6 mice infected in parallel with animals used for 30 dpi luciferase analy-
sis (Fig 3). Comparison between luciferase signals obtained at days 30 and 120 post-infection
revealed a decrease in signal across both LAT-positive and LAT-negative virus infections rang-
ing from 1.9–6.8-fold (Fig 6A and 6B). Decreases in luciferase signal between 30 and 120 dpi
were both significant and most pronounced during LAT-negative infection (Fig 6A and 6B).
Whilst these data are consistent with previous work describing decreasing reporter gene
expression during latent infection from both HSV-1 promoters and heterologous promoters
such as the HCMVMIEP [15, 18–20], the greater loss of luciferase expression during LAT-neg-
ative virus infection may indicate: a) that neurons harbouring transcriptionally active HSV-1
are destroyed, or conversely b) that LAT expression may aid the maintenance of gene expres-
sion in SC16CMVluc and SC16CMVlucREV viruses over time.
LAT-negative HSV-1 recombinants reactivate more frequently during ex
vivo culture of individual neurons
After using the aforementioned reporter gene experiments to study the very earliest stages of
HSV-1 exit from latency, it was pertinent to assess whether our conclusions could be corrobo-
rated in studies of full reactivation and virus production. In order to assess the frequency of
reactivation at the single cell level, we utilised an Ai6 ZsGreen reporter mouse [21] model of
infection that allows for the marking and isolation of individual latency infected cells [22]. Fol-
lowing infection with Cre recombinase-expressing HSV-1 recombinants, excision of a lox-
stop-lox cassette within infected cells leads to the permanent expression of ZsGreen fluores-
cence protein, allowing for visualisation of the latent cell reservoir (Fig 7A). All cells marked by
ZsGreen fluorescence contain latent HSV-1 DNA [22].
Fig 5. β-galactosidase reporter viruses reveal an increased frequency of gene expression in the absence of the LAT RNAs. a) Genomic structures of
SC16CMVlacZΔLAT-GFP and SC16CMVlacZREV. Both viruses harbour an HCMVMIEP-lacZ expression cassette within the non-essential HSV-1 US5
locus. b) Virus titres obtained from the whisker pads (WP) and trigeminal ganglia (TG) of C57BL/6, at 4 and 5 dpi. Symbols and error bars represent mean
titre ± SEM from 5mice per virus per time-point. c) LAT expression quantified by qRT-PCR from total TG pair cDNA. Each symbol represents HSV-1 major
LAT intron RNA per 104 copies of cellular cyclophilin A in each TG pair (N = 5 mice per virus) and floating bars represent the median of these data.
Significantly less major LAT RNA was detected in SC16CMVlacZΔLAT-GFP-infected TG compared to the revertant—P = 0.0079, Mann-Whitney U test. d)
Photomicrograph of β-galactosidase-positive neurons during latent infection of C57BL/6 TG. e) Quantification of β-galactosidase-positive cells during latent
infection with SC16CMVlacZΔLAT-GFP and SC16CMVlacZREV. Each symbol represents the number of positive cells per TG (N = 10) and floating bars
represent the mean of these data. SC16CMVlacZΔLAT-GFP-infected TG possessed significantly more positive cells than the revertant—P < 0.0005,
Student's t-test. f) Virus DNA loads quantified by qPCR. HSV-1 DNA was normalised to the cellular control, APRT. Each symbol represents normalised HSV-
1 DNA per TG pair (N = 5) and floating bars represent the mean of these data.
doi:10.1371/journal.ppat.1005539.g005
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Ai6 reporter mice were infected with 5x106 pfu per whisker pad with the aforementioned
LAT-negative recombinant virus SC16CMVCreΔLAT-GFP or its revertant,
SC16CMVCreREV, which express Cre recombinase from the HCMVMIEP within the non-
essential US5 locus [12]. Between 28–30 dpi, three mice were killed per virus and TGs were dis-
sected. TGs were dissociated into single cell suspensions as described in Materials and Meth-
ods. Individual fluorescent cells (n = 226–227) were removed from the cell suspension, placed
on to MRC5 cell monolayers and monitored for virus reactivation over 8 days. Visual assess-
ment of neuron cell body fragmentation (Fig 7B and 7C) revealed a steady loss of viable cells
over the duration of the experiment, with just 32.3% and 30.4% fluorescent neurons remaining
eight days post-explant for SC16CMVCreΔLAT-GFP and SC16CMVCreREV, respectively (Fig
7D). As well as providing a feeder cell layer for neuron adhesion, MRC5 cells are permissive to
HSV-1 replication and allow for the detection of reactivating virus by visual assessment of CPE
(Fig 7E–7H). One day post-explant, cells were heat-shocked by culturing at 43°C for 2 hours to
stimulate reactivation [23]. Reactivation events were rare, with 4.1% and 1.3% of wells reacti-
vating from SC16CMVCreΔLAT-GFP and SC16CMVCreREV-infected neurons, respectively
(Fig 7I). In a separate experiment, neurons latently infected with SC16CMVCre and
SC16CMVCreΔLAT-GFP were cultured in the absence of a heat-shock reactivation stimulus.
Low rates of reactivation were again observed over an eight day period, with 6.1% and 3.0%
reactivation by day eight for SC16CMVCreΔLAT-GFP and SC16CMVCre, respectively (S5
Fig). These data demonstrate that, at the level of individual neurons, reactivation is both lim-
ited to a minority of cells and occurs at roughly twice the frequency when the cell population is
Fig 6. Luciferase expression decreases following long-term latent infection. a) Luciferase signal was quantified with Living Image software and
normalised to relative HSV-1 DNA loads within the same TGs. Data acquisition was performed separately on 30 and 120 dpi. Each symbol represents
normalised luciferase signal from an individual TG. Floating bars represent the median signal of each virus group. A signal of 1x104 ps-1cm-2sr-1 represents a
background threshold of detection. A significant reduction in luciferase signal was observed for both LAT-negative viruses (P < 0.01). b) The fold-decrease in
median luciferase signal between day 30 and 120 post-infection for SC16CMVluc, SC16CMVlucΔLAT-GFP-1, SC16CMVlucΔLAT-GFP-2 and
SC16CMVlucREV, respectively. A formal statistical comparison between viruses is not possible from these data.
doi:10.1371/journal.ppat.1005539.g006
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infected with LAT-negative HSV-1. To ascertain whether these increased reactivation kinetics
could be attributed to increased HSV-1 DNA loads within cells infected with LAT-negative
virus, TG from Ai6 mice were dissected 30 dpi and dissociated to cell suspensions. Individual
fluorescent neurons were picked for single cell qPCR (n = 47–61 cells per virus group). The dis-
tribution of HSV DNA copies per cell was highly similar between SC16CMVCre,
SC16CMVCreΔLAT-GFP and SC16CMVCreREV-infected neurons (Fig 7J), suggesting that
Fig 7. Analysis of latency at the single cell level reveals an increased frequency of reactivation during infection with LAT-negative HSV-1. a)
Genomic structures of the Ai6 ZsGreen transgenic locus before and after HSV-1 Cre-mediated excision of the lox-STOP-lox cassette. The constitutively
active CAG promoter drives expression of the locus. Following excision of the lox-STOP-lox cassette, ZsGreen mRNA is stabilised by theWoodchuck
Hepatitis Virus Post-transcriptional Regulatory Element (WPRE). b) Fluorescence photomicrograph of an intact latently infected Ai6 neuron in MRC5 culture.
c) Fluorescence photomicrograph of a dying latently infected Ai6 neuron in MRC5 culture. d) Neuron fragmentation was recorded each day during an eight
day culture on MRC5 cells as an indicator of cell survival in culture. e) Photomicrograph of uninfected MRC5. f) Photomicrograph of MRC5 displaying HSV-1
cytopathic effect. g,h) Fluorescence photomicrographs of latently infected neurons undergoing reactivation. MRC5 CPE is visible in close proximity to the
cultured neurons (arrows). i) Cumulative reactivation observed from ex vivo cultures of neurons latently infected with SC16CMVCreΔLAT-GFP and revertant
virus, as assessed by CPE in the MRC5 feeder layer (n = 6 mice per virus). Symbols represent average percentage reactivation per day and error bars
represent ± SEM. * represents P < 0.05; Student's T-test. j) Single cell HSV-1 DNA loads were distributed equivalently between LAT-positive and LAT-
negative virus recombinants. Each symbol represents the HSV-1 genome copy in an individual fluorescent neuron. Floating bars represent median copies
per cell in each virus group.
doi:10.1371/journal.ppat.1005539.g007
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the observed reactivation phenotype was solely due to the absence of LAT expression during
latency in Ai6 mice.
In summary, these ex vivo data, in conjunction with our observations from independent
reporter virus analyses of whole infected ganglia, indicate that LAT expression aids the sup-
pression of HSV-1 reactivation in mice by repressing gene expression from the latent virus
genome.
Discussion
In this study we have generated luciferase and β-galactosidase-expressing HSV-1 recombinants
in order to examine reporter gene expression at the level of both whole ganglia and single cells.
We have observed that LAT-negative virus infections express higher levels of reporter gene
during latency in TG, and this is probably the result of an increased number of infected cells in
which virus gene expression occurs at any one time. Furthermore, by isolating individual
latently infected cells and culturing ex vivo, this heightened gene expression is mirrored by a
detectable increase in reactivation at the single cell level. Whilst we cannot formally rule out
down-regulation of both firefly luciferase and β-galactosidase reporter genes by HSV-1 micro-
RNAs, we propose that HSV-1 LAT expression limits the rate of virus reactivation, and does so
by restricting gene expression from the latent genome.
We have previously described that LAT-negative viruses establish latency in a greater num-
ber of TG cells, relative to LAT-positive virus [12]. It is reasonable to suggest this may have
resulted in the greater luciferase and β-galactosidase gene expression observed in this study.
However, given that the infection dose, methodology and animal system (mice in both studies
were based on the C57BL/6 genetic background) are identical, LAT-negative HSV-1 would be
expected to establish latency in 25% more neurons than LAT-positive virus [12]. Such a num-
ber of cells is too few to account for the 7.9-fold greater number of β-galactosidase-positive
cells and 2.1–4.9-fold higher luciferase signal observed during infection with independent
LAT-negative recombinants in this study. Furthermore, measurements of luciferase signal
were normalised to latent HSV-1 DNA loads within matched TGs (Fig 3), confirming that dif-
fering total virus DNA loads could not alone account for our observations. Taken together,
these data provide robust experimental evidence that the LAT RNAs repress gene expression
from the latent HSV-1 genome.
These findings corroborate an important observation by Chen and colleagues, in which
increased transcription of ICP4 and TK per virus genome (5- and 10-fold, respectively) was
observed during latent infection with a LAT-deletion virus [6]. Further evidence for a repres-
sive role of the LAT comes from studies using ChIP assays to investigate the histone PTMs
associated with the latent genome. Such studies have determined that LAT expression is posi-
tively correlated with a larger enrichment of constitutive and facultative heterochromatin upon
HSV-1 lytic promoters [9, 10]. Indeed, following our observations of increased luciferase
expression during LAT-negative HSV-1 latency, we too sought to characterise the enrichment
of trimethylated H3K27 and pan-acetylated H3, markers of facultative heterochromatin and
euchromatin, respectively. During latent infection with all four luciferase reporter viruses we
determined that the vast majority of latent genomes were under strong epigenetic repression.
Latent genomes were associated with minimal H3ac (S2 Fig) and were highly enriched with
H3K27me3 (Fig 4C). This was unexpected for the LAT enhancer sequence due to its previous
characterisation as a hyperacetylated region in both LAT-positive and LAT-negative viruses
[24]. However, as our qPCR amplified sequence upstream of that described by Kubat and col-
leagues, this discrepancy could be reconciled if acetylated H3 enrichment is highly non-uni-
form across the entire enhancer. The reciprocal enrichment in H3K27me3 supports that the
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region under study was highly associated with facultative heterochromatin. Overall, the obser-
vation that the latent HSV-1 genomes were highly repressed was unsurprising, as reporter gene
analysis with β-galactosidase-expressing viruses determined that only a small minority of
infected neurons in each TG were positive for detectable levels of gene expression: roughly
2–13 cells (Fig 5) in an infected cell population estimated to number 500–800 latently infected
cells per TG [12]. Whilst it is possible that β-galactosidase expression could have occurred in
all infected neurons, but only to sufficiently high levels to detect in a small population of cells
(therefore leading to an underestimation of the frequency of de-repressed HSV-1 DNA), our
inability to detect acetylated H3 enrichment on the firefly luciferase genes inserted at HSV-1
US5 (the same locus as found in the lacZ reporter viruses) does not support such a view. There-
fore, following inoculation and primary infection in the mouse whisker pads, it is likely that
the majority of latently infected cells contain tightly repressed genomes, with viral lytic (or
reporter gene) transcription occurring in just a small number of neurons at any one time.
Despite this, our inability to determine a significant difference in heterochromatin enrichment
between LAT-positive and LAT-negative luciferase viruses conflicts with previous reports [7–
10]. Whilst different HSV-1 strains have been suggested as a source of variation in ChIP results
between research groups [8], if the LAT truly confers HSV-1 with the ability to regulate chro-
matin modifications, it would seem probable that a conservation of function should exist
between strains. Of likely greater importance is the inconsistency between infection methods–
namely the route of virus inoculation (whisker pad, corneal and footpad scarification) and the
site of latency (TG vs dorsal root ganglia, DRG). For example, we and others have previously
shown that LAT expression influences latency establishment in TG but not DRG [12, 25],
which suggests an anatomical dependence of LAT function. Furthermore, as corneal scarifica-
tion has been reported to infect nearly 30% of TG neurons with a number of HSV-1 strains
[26], whisker pad scarification appears to lead to a more restricted establishment of latency,
with ~500 neurons latently infected [12] out of approximately 20,000 [27] (~2.5%).
Despite this, we did observe less H3K27me3 enrichment upon both the LAT enhancer and
5’ CDS of the firefly luciferase gene of LAT-negative HSV-1 recombinants during latency (Fig
4C). Whilst these data were not determined as statistically significant, such a decrease in het-
erochromatin enrichment was expected due to the increased luciferase activity observed during
LAT-negative infection. Whilst differences in H3K27me3 enrichment at the LAT enhancer
could be influenced by the neighbouring HCMVMIEP, microRNA expression within and
adjacent to the LAT was not significantly different between LAT-negative viruses with or with-
out insertion of the MIEP (S3 Fig), suggesting no effect on neighbouring gene regulation
occurred as a result of the exogenous promoter. The equivalent level of reporter gene expres-
sion from the US5 locus observed from both LAT-negative viruses in the same experiment also
suggests no long-range effect of the HCMVMIEP located in the LAT locus (S3E Fig).
Our observations that all four viruses were similarly highly repressed, as well as the detec-
tion of few β-galactosidase-positive cells within latent TGs, suggest that LAT-mediated epige-
netic regulation does not occur uniformly across HSV-1 cell reservoirs. It is likely that our
ChIP assay was simply not sensitive enough to detect genome de-repression from pooled TG
samples. If reporter gene expression were only able to occur in 0.3–2.2% of the infected cell
population (e.g. 2–13 cells among 500–600), the remaining transcriptionally silent 97.8–99.7%
of the population would most heavily influence the outcome of our ChIP analyses. Future anal-
ysis of LAT function in single cells will likely provide more conclusive data to support the
extent and mechanism by which LAT enhances HSV-1 genome silencing. Whilst we have been
largely unable to determine an effect of LAT expression upon H3K27me3 enrichment, in total
our data support a repressive role for the LAT during latency. Furthermore, small non-coding-
and microRNAs processed from, or adjacent to, the LAT locus appear to actively target lytic
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gene expression [3, 4, 28, 29]. We believe that, on balance, the collected evidence suggests that
at least one function of LAT transcription is to repress virus lytic gene expression.
Results from our single cell reactivation analyses also present further evidence that the LAT
RNAs possess an inhibitory role during HSV-1 latency. It is widely reported that LAT-negative
HSV-1 mutants possess a reactivation deficit [30–32]. Other studies have reported not only
that LAT impacts upon the number of cells in which latency is established [12, 33, 34], but that
the number of neurons in which latency is established directly correlates with reactivation [35].
Within our study we sought to assess reactivation from a known number of independent neu-
rons cultured ex vivo. To do this, we infected Ai6 ZsGreen transgenic mice with Cre recombi-
nase-expressing reporter viruses to permanently mark latently infected cells within the mouse
TG. By dissociating ganglia and picking individual cells, we were able to culture neurons inde-
pendently from the remaining ganglion tissue and assess reactivation frequency from single
neurons. During these experiments we observed a higher reactivation frequency from neurons
infected with LAT-negative HSV-1, relative to wildtype and revertant viruses (Fig 7 and S5
Fig). These data suggest that as a result of restricting HSV-1 gene expression, LAT-positive
virus reactivation frequency is also reduced. Whilst these data conflict with aforementioned
studies describing reactivation deficits from LAT mutants, in these reports it is not possible to
determine the number of neurons in which latency was established, a factor with strong posi-
tive correlation to the efficiency of reactivation in the mouse [33, 35]. A reported deficit in
latency establishment in the rabbit [34] may also explain the defective spontaneous reactivation
observed with LAT-negative HSV-1 [32] in this model. In the present study, we determined
that LAT-negative HSV-1 reactivated with higher frequency from a known number of single
neurons, greatly reducing potential biases from latency establishment. Furthermore, from sin-
gle cell PCR with individual neurons, we determined that LAT expression had no influence on
the distribution of viral DNA in the latent population. It is therefore unlikely that LAT-nega-
tive HSV-1 reactivation was influenced by gross differences in viral load per neuron. The over-
all rate of reactivation we observed was low. One reason for this low incidence is likely to be the
death of picked cells in culture. Indeed, over an eight-day duration, roughly 70% of neuronal
cell bodies had fragmented. We did not observe reactivation from any neuron after it was
recorded as dead. Previous studies assessing reactivation at the single cell level have also
reported a low incidence of recurrence. For example, an average of 2.3 HSV-1 antigen-positive
neurons per TG were detected 22 hours post-reactivation stimuli both in vivo and ex vivo [36],
and just 23 infectious centres were observed following superinfection of wildtype TG cultures
ex vivo [37]. In the present study, roughly 70 individual neurons were picked from a single cell
suspension from each dissected mouse. Qualitatively, this did not comprise the majority of the
fluorescently labelled cell reservoir, and thus the number of neurons observed to reactivate was
likely lower than if we had analysed every infected cell within each TG pair. Spontaneous reac-
tivation within the mouse model is yet more infrequent [12, 38] and thus it is likely that a small
pool of reactivation-competent cells exists within the mouse TG. However, it remains unclear
why reactivation occurs in one neuron yet latency persists in another. Clearly, the inability to
express the LAT does not guarantee that reactivation will occur, as 93–96% of our neurons did
not reactivate. Indeed, multiple factors are thought to be required for full reactivation, includ-
ing de novo synthesis of VP16 [39], as well as VP16 and/or HCF-1 relocalization from the cyto-
plasm to the nucleus [40, 41]. Using an elegant fluorescent in situ hybridisation approach, it
has been determined that LAT transcription most often occurs within neurons infected with
multiple copies of the HSV-1 genome, and is negatively regulated by association with promye-
locytic leukemia (PML) nuclear bodies and centromeres [42]. Whilst these observations sug-
gest that neurons containing few copies of the HSV-1 genome may be sufficiently repressed by
cellular factors, experiments from our laboratory show that reactivation can occur from
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neurons harbouring low copy numbers (despite occurring at an increased frequency when
latent HSV-1 genomes are more numerous) [22].These data are in agreement with the observa-
tion that the reactivation competence of HSV-1 strains positively correlates with the average
viral genome copy within individual neurons [26].
We have previously reported that infected cell numbers are less stably maintained in the
absence of LAT expression [12]. In the current study we hypothesised that this loss may occur in
populations of neurons possessing transcriptionally active HSV-1 genomes. Indeed, when we
compared luciferase expression between 30 and 120 days, we did observe a significant decrease in
reporter gene activity during LAT-negative infection, with a smaller reduction also observed dur-
ing LAT-positive virus infection (Fig 6). Whilst these observations support our hypothesis, they
do not rule out the possibility that LAT expression could have prolonged the long-term expression
of firefly luciferase, thus decreasing the relative loss of signal observed from viruses SC16CMVluc
and SC16CMVlucREV. Such an interpretation is supported by reports describing decreased lytic
gene transcription during latency from a LAT promoter deletion mutant in rabbits [7], as well as
an enhanced enrichment of the same mutant with facultative heterochromatin marker
H3K27me3 relative to wildtype HSV-1 [8]. However, we interpret the sum of our data to support
the LAT as a general repressor of gene expression, in agreement with other analyses of latent gene
expression [2, 6] and PTM of chromatin upon the HSV genome [9, 10]. Given this interpretation,
we currently favour the explanation that we are observing a loss of infected cells with time.
Whilst we are unable to dismiss the possibility that such a loss of luciferase signal would not
be due to the mouse immune system targeting firefly luciferase- or GFP-positive cells for
destruction, we have previously observed a reduction in latently infected cell numbers with
both GFP-positive and GFP-negative LAT-deficient viruses [12], suggesting that cell death
would not solely be due to reporter gene recognition by the immune system. Therefore, we
believe that whilst transcriptionally permissive cells are those that are lost during infection, this
is either a result of cytolytic reactivation or immune detection of viral proteins, and is exacer-
bated by an absence of LAT transcription in those cells.
In summary, our studies suggest that the HSV-1 latency-associated transcript reduces the
frequency of reactivation at the single cell level, and do so by globally repressing virus gene
expression. We have also provided further evidence that LAT expression leads to a more stable
maintenance of latency throughout long-term infection, which may serve to increase the
potential for transmission of the virus throughout the life of the host.
Materials and Methods
Cells and viruses
All viruses were derived from HSV-1 strain SC16 [43]. Baby hamster kidney (BHK) cells
(American Type Culture Collection CCL-10) were used for virus stock production and plaque
assays and were maintained in Dulbecco's modified Eagle's medium (DMEM) containing 10%
foetal calf serum (FCS), 10% tryptose phosphate broth, 2 mM L-glutamine, penicillin (100 U/
ml), and streptomycin (100 μg/ml) (PAA laboratories). MRC5 cells (American Type Culture
Collection CCL-171) were used for reactivation experiments and were maintained in Dulbec-
co's modified Eagle's medium (DMEM) containing 10% foetal calf serum (FCS), 2 mM L-gluta-
mine, penicillin (100 U/ml), streptomycin (100 μg/ml) (PAA laboratories) and supplemented
with non-essential amino acids (Gibco). All cells were incubated at 37°C and 5% CO2.
Plasmids
All HSV-1 genetic coordinates used throughout this study were determined from GenBank
accession number NC_001806 [44].
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pHD5-CMVluc contains a 2,833 bp fragment consisting of the human cytomegalovirus
(HCMV) major immediate early promoter (MIEP) of pcDNA3 (Invitrogen) adjacent to the
firefly luciferase and polyA signal from pGL4.10[luc2] (Promega), inserted into the synthetic
polylinker of plasmid pHD5 [15], inserting the expression cassette at HSV-1 nt 137,945 in the
Unique-Short 5 (US5) open reading frame.
pPSTD1 [45] comprises a 3.3 kbHpaI fragment of HSV-1 strain SC16 (HSV-1 nucleotides
[nt] 117010 to 120301), containing the HSV-1 LAT promoter.
pPSTDΔLAT-CMVGFP [12] was derived from pPSTD1 and contains a 1,369-bp NsiI-PstI
fragment derived from pEGFP-C1 (Clontech) encoding green fluorescent protein (GFP) under
the control of the HCMVMIEP in place of the 203 bp PstI LAT promoter (LAP).
pGAL1 [46] comprises the 3.8 kb HCMVMIEP lacZ-expression cassette of pMV10 [46]
inserted into the HSV-1 US5 open reading frame (HSV nt 137,945).
Construction and characterization of recombinant viruses
HSV-luc has been previously characterised [14]. In this work we here term the virus
SC16CMVluc with reference to the other recombinants described in this study. This virus con-
tains the 2,833 bp firefly luciferase expression cassette from pHD5-CMVluc inserted at HSV nt
137,945.
SC16CMVlucΔLAT-GFP-1 was constructed by cotransfecting BamHI-linearized
pPSTDΔLAT-CMVGFP and SC16CMVluc-infected cell DNA to produce a virus in which the
203 bp LAP sequence was replaced by the HCMVMIEP GFP cassette in both Repeat-Long
(RL) genomic regions. GFP is transcribed by the HCMVMIEP in the opposite orientation to
the LAT locus.
SC16CMVlucΔLAT-GFP-2 was constructed by cotransfecting PstI-linearized
pHD5-CMVluc and HSV CMVCreΔLAT-GFP-infected cell DNA to introduce the 2,833 bp
firefly luciferase expression cassette into the US5 region (HSV nt 137,945) of a previously char-
acterised LAT promoter-negative HSV-1 recombinant [12].
SC16CMVlucREV was constructed by cotransfecting BamHI-linearized pPSTD1 and
SC16CMVlucΔLAT-GFP-2-infected cell DNA to produce a GFP-negative virus restored for
the core LAT promoter in both RL genomic regions.
SC16CMVlacZΔLAT-GFP was constructed by cotransfecting XmnI-linearized pGAL1 and
HSV CMVCreΔLAT-GFP-infected cell DNA to introduce the 3.8 kb β-galactosidase expres-
sion cassette into the US5 region (HSV nt 137,945) of a previously characterised LAT pro-
moter-negative HSV-1 recombinant.
SC16CMVlacZREV was constructed by cotransfecting BamHI-linearized pPSTD1 and
SC16CMVlacZΔLAT-GFP-infected cell DNA to produce a β-galactosidase-expressing virus
restored for the core LAT promoter in both RL genomic regions.
All virus recombinants were isolated and plaque purified by limiting dilution following
assessment of luciferase activity, β-galactosidase-expression or GFP-positivity/negativity where
applicable.
In vitro growth curve analyses
Growth curves were performed in BHK cell monolayers at 0.01 pfu per cell, as previously
described [12]. Briefly, cells were incubated for 1 h, and extracellular virus was inactivated
with citric acid solution (135 mM NaCl, 10 mM KCl, 40 mM citric acid). Infected cell
monolayers were sampled at set time points over a 72-h period and stored at −70°C prior to
assay.
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Mouse infection
Whisker pad infections were conducted in female C57BL/6 mice (Harlan, United Kingdom) at
8 weeks of age (unless otherwise specified), as previously described [12]. Briefly, animals were
anaesthetised by isoflurane inhalation and scarified through 40μl of virus inoculum (106 pfu)
on both whisker pads. Whisker pad infections were also conducted in male and female Ai6
ZsGreen mice [21] at 8 weeks of age, but with inoculum titres of 5x106 pfu per whisker pad.
Mice were killed by rising CO2 asphyxiation and dissected tissues were freeze-thawed, homoge-
nized, and freeze-thawed once more prior to assay.
Ethics statement
All animal experiments were approved by the University of Cambridge ethical review board
and by the UK Home Office under the 1986 Animal (Scientific Procedures) Act as Project
Licenses 80/2205 and 70/7889.
Enumeration of β-galactosidase-positive cells in latently infected TG
Following inoculation with β-galactosidase-expressing recombinant viruses, mice were killed
by CO2 asphyxiation 30 dpi and TGs were dissected to complete DMEM. TGs were fixed on
ice for 1.5 hours in 4% paraformaldehyde-phosphate-buffered saline and incubated in X-Gal
(5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) as described previously [47]. β-galactosi-
dase-expressing cell numbers per TG were determined by microscopy.
Single cell reactivation assays
Ai6 ZsGreen reporter mice were infected with 5x106 pfu per whisker pad. Mice were killed by
CO2 asphyxiation 30 dpi and TGs were dissected to complete DMEM on ice. To prepare single
cell suspensions, TGs were finely minced and incubated in liberase (0.7 units ml-1) (Roche)
and DNAse I (Life Technologies) in serum-free DMEM at 37°C for one hour and were gently
triturated every 20 minutes with a Gilson pipette. Neurons were layered on top of a 5-step
OptiPrep gradient (Sigma) [10, 15, 20, 25 and 30% densities in DMEM supplemented with
10% FCS). Following centrifugation at 800 x g for 15 minutes at 10°C, neuron containing layers
(the lower 60% of the gradient volume) was removed, pelleted and washed before resuspension
in complete DMEM. Fluorescent latently infected neurons were observed with an Olympus
IX70 inverted fluorescence microscope and were manipulated using flame-pulled Pasteur
pipettes. Neurons were individually picked on to confluent MRC5 cell monolayers in 96-well
plates. Enriched neurons were maintained on ice for the duration of the procedure. Plates were
incubated at 37°C and 5% CO2 and visually assessed for cell body fragmentation and the devel-
opment of CPE on a daily basis. One day post-explant, cells were heat-shocked by culturing at
43°C for 2 hours to stimulate reactivation.
96-well assessment of luciferase activity
To isolate luciferase-expressing HSV-1 recombinants, growth medium was removed following
the onset of CPE and frozen at -70°C for later virus isolation. To each well of cells, 50 μl of
luciferase lysis buffer (1% Triton-X-100, 1mM DTT, in gly-gly buffer [0.025 M glycylglycine
pH 7.8, 0.015 MMgSO4, 4 mM EGTA]) was added, and incubated at RT for 10 minutes. 25 μl
of cell lysate was assayed in an opaque 96-well luminometer plate. 92 μl of assay buffer (7.5 ml
gly-gly buffer, 1.5 ml KPO4 buffer [1 M KH2PO4, 0.1 M K2HPO4, pH 7.8.], 1 mMDTT, 2.5
mM ATP) was added to each well and mixed. The plate was then loaded into a GloMax 96-well
plate reader (Promega) and luciferase activity in each well measured before and after injection
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of 25 μl luciferin solution (0.2 mM luciferin (Sigma) and 0.1 mMDTT dissolved in gly-gly
buffer). The same methodology was utilised to analyse luciferase expression from TGs dis-
sected during acute infection, except that TGs from each mouse were each homogenised in
200 μl lysis buffer and 25 μl of lysate was assessed in duplicate.
In vivo luciferase imaging
Infected mice were anesthetised with isofluorane and I.P. injected with 1.5 mg D-luciferin dis-
solved in 100 μl of magnesium- and calcium-free PBS. Images of live mice were acquired 15
minutes post-injection of D-luciferin for a duration of 1 minute, using an IVIS imaging cabinet
and charge-coupled device camera (Caliper Life Sciences). To image latently infected TGs,
mice were killed by rising CO2 asphyxiation 13 minutes after injection of D-luciferin and dis-
sected TGs were imaged 3 minutes later. In total, dissected TGs were imaged 22 minutes post-
injection of D-luciferin, with images captured for two minutes to increase the sensitivity of sig-
nal detection.
Nucleic acid extraction for quantitative PCR (qPCR) and reverse
transcriptase qPCR
For assessment of viral DNA loads, individual TGs were homogenized and incubated in 0.5%
sodium dodecyl sulfate (SDS) and 50 μg of proteinase K/ml in TE buffer (10 mM Tris HCl, 1
mM EDTA [pH 8]) overnight at 37°C. To purify the extracted DNA, samples were phenol
chloroform extracted and ethanol precipitated. For assessment of LAT expression during
latency, individual TGs were homogenized in 1ml TRIzol (Life Technologies) and RNA
extracted following the manufacturer's protocol. Total RNA was reverse transcribed using ran-
dom primers and Superscript III reverse transcriptase (RT) (Life Technologies), alongside RT-
negative control RNA.
Chromatin immunoprecipitation (ChIP) assays
To assess the enrichment of acetylated and trimethylated histone 3 protein on latent HSV-1
genomes, for each virus TGs were pooled from 3 mice and fixed with 1% formaldehyde for 15
min at room temperate. Fixative was removed and TGs added to cold 300 μl lysis buffer (1%
SDS, 10mM EDTA, 50 mM Tris-HCl, pH 8.0) containing EDTA-free protease inhibitors
(Roche) and 1 mM PMSF (Roche). TGs were lysed in a glass homogenizor for two minutes and
the cell lysate sonicated (Qsonica Sonicator Q700; Fisher-Scientific) at 90% amplitude
(~250W/sec) for 4 ½ minutes at 4˚C. Input (INP) and IP aliquots from each preparation were
snap frozen and stored at -70°C. Thawed IP samples were diluted 1:10 in dilution buffer (1%
TritonX-100, 2mM EDTA, 150 mMNaCl, 20 mM Tris-Cl [pH 8.0]) containing EDTA-free
protease inhibitors (Roche) and 1 mM PMSF (Roche). IP samples were pre-cleared with 100 μl
protein A-Sepharose (Sigma) [in 5 ml dilution buffer containing 1 mg salmon sperm DNA
ml−1, 1 mg BSA ml−1 and 0.02% sodium azide] O/N at 4˚C. IP supernatants were incubated
with 20μl anti-pan-acetylated H3 polyclonal antibody [Millipore 06–599] or 10μl anti-
H3K27me3 polyclonal antibody [Millipore 07–499] O/N at 4˚C. Antibody–antigen complexes
were isolated with protein A–Sepharose beads O/N at 4˚C and non-specific binding removed
with the following washes: 1.5 ml dilution buffer, 1.5 ml TSE (0.1% SDS, 1% TritonX-100,
2mM EDTA, 150mMNaCl), 1.5 TSE + 500 mMNaCl, 1.5 ml Buffer III (0.25 M LiCl, 1%
NP40, 1% Na desoxycholate, 1 mM EDTA, 10 mM Tris-Cl [pH 8.0]) and 1.5 ml TE. Antibody-
antigen complexes were eluted by incubation with 1% SDS in 0.1 M NaHCO3 and subsequently
incubated with 0.2 M NaCl at 65 °C O/N to reverse cross-linking. DNA was purified by
LAT Represses Latent HSV-1 Gene Expression
PLOS Pathogens | DOI:10.1371/journal.ppat.1005539 April 7, 2016 19 / 24
treatment with proteinase K followed by phenol/chloroform extraction. The DNA was isolated
by ethanol precipitation following the addition of glycogen and tRNA as carrier.
Quantitative polymerase chain reaction (qPCR)
qPCRs were conducted as previously described [7]. To determine viral loads within latent
TGs, HSV-1 genomes were quantified with ICP0 promoter-specific primers and probe, and
normalised to the cellular housekeeping gene adenine phosphoribosyltransferase (APRT) in
duplex reactions. LAT expression was quantified with major LAT-specific primers and
probe, and normalised to the cellular housekeeping gene cyclophilin A. PCR products were
quantified using a Corbett Research Rotor-Gene and calculated from triplicate results from
each PCR. A standard curve for each gene region was generated using dilutions of appropri-
ate plasmids. Reaction conditions utilized were 15 min at 95°C, with 45 cycles of 15 s at 95°C
and 60 s at 60°C. All primer and TaqMan probe sequences used in this study are displayed
in Table 1.
Statistical analyses
Analysis of virus titres was conducted using one-way analysis of variance. Analysis of luciferase
signal and viral DNA loads were conducted using the Mann-Whitney U and Kruskal-Wallis
tests for paired- and multiple-group analyses, respectively.
Table 1. Primers and TaqMan probes used in this study.
Primer Sequence (5' -3')
HSV-1 ICP0pro F GGAAAGGCGTGGGGTATAA
HSV-1 ICP0pro R AACGTAGGCGGGGCTTC
HSV-1 ICP0pro TM TCGCATTTGCACCTCGGCAC
HSV-1 VP16pro F CGGATTGGGAAACAAAGGC
HSV-1 VP16pro R CGCACAGACGAAGACCTCA
HSV-1 VP16pro TM ACCGAATGAACCCCTGTTGGTGCT
HSV-1 LAT enhancer F GGCGTCGGCGACATCC
HSV-1 LAT enhancer R CCCGAGTGTTCATCTCAGGC
HSV-1 LAT enhancer TM AAACCCGTCTGGGGTGTTTTTCGTTCC
HSV-1 Major LAT F CCAGGCAGTAAGACCCAAGC
HSV-1 Major LAT R GGCCGGTGTCGCTGTAAC
HSV-1 Major LAT TM TCCCACCCCGCCTGTGTTTTT
Fireﬂy luc 5' CDS F GGCCCAGCGCCATTCTA
Fireﬂy luc 5' CDS R ACAGCCACACCGATGAACAG
Fireﬂy luc 5' CDS TM CCACTCGAAGACGGGACCGCC
Mouse APRT F GGGGCAAAACCAAAAAAGGA
Mouse APRT R TGTGTGTGGGGCCTGAGTC
Mouse APRT TM TGCCTAAACACAAGCATCCCTACCTCAA
Mouse upHoxa5 F CTGTGGGACAGACGCACTGTAC
Mouse upHoxa5 R GCTCCTTCTTCCCCCACAAC
Mouse upHoxa5 TM AGGGCCAATTCTGGGTGCATCGC
Mouse cyclophilin F GTCTCCTTCGAGCTGTTTGC
Mouse cyclophilin R GAGGAACCCTTATAGCCAAATCC
Mouse cyclophilin TM ACAAAGTTCCAAAGACAGCAGAAAACTTTC
doi:10.1371/journal.ppat.1005539.t001
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Supporting information
Additional information for supporting experimental data can be found in Supporting Methods
(S1 Methods).
Supporting Information
S1 Fig. Luciferase expression is higher during LAT-negative HSV-1 infection in latent tri-
geminal ganglia pairs. Following injection of D-luciferin substrate, TGs were dissected at set
times from each mouse. Luciferase signal was accurately quantified with Living Image software
and normalised to relative HSV-1 DNA loads within the same TGs. Each symbol represents
normalised luciferase signal from a pair of TG. Floating bars represent the median signal of
each virus group. A signal of 1x104 ps-1cm-2sr-1 represents a background threshold of detec-
tion.
(TIF)
S2 Fig. Pan-acetylated H3 enrichment on viral and cellular DNA. a) Fold enrichment of
upHoxa5 and three virus sequences with euchromatin marker H3ac. The histogram displays
the average of four independent experiments (+ SEM), each comprising groups of three pooled
TGs per virus. Fold enrichment of H3ac immunoprecipitation (IP) was calculated as: [Virus
sequence IP (IP + Input)] [cellular APRT IP (IP + Input)]. b) Dot plot displaying the
enrichment of H3ac on the HSV-1 LAT enhancer observed from four biological repeats. Sym-
bols represent relative enrichment of sequences from three pooled TGs per virus. Fold enrich-
ment of H3ac IP was calculated as in a).
(TIF)
S3 Fig. MicroRNA and reporter mRNA transcription in different HSV-1 LAT mutants.
RNA and DNA were isolated from matched groups of male and female C57BL/6 mice TG
17dpi with HSV-1 recombinants SC16CMVCre, SC16CMVCreΔLAT and SC16CMVCre-
ΔLAT-GFP. The latter two both carry deletion of the 203bp LAP, but only SC16CMVCre-
ΔLAT-GFP harbours an HCMV-MIEP GFP cassette in its place. Each symbol represents
normalised RNA or DNA from one pair of TG and floating bars represent the median of each
group for levels of a) miR-H1-5p, b) miR-H2-3p, c) miR-H4-5p, d) miR-H6-3p, e) Cre recom-
binase mRNA and f) HSV-1 genomes. Fractions above each group denote the number of TG
positive for the quantified nucleic acid species. No significant difference was observed between
LAT-negative viruses in any assay (Kruskal-Wallis with Mann-Whitney post-tests–see S1
Dataset for details of full statistical comparison).
(TIF)
S4 Fig. Generation of Β-galactosidase reporter viruses. a) Genomic structure of SC16 BE8. b)
Virus titres obtained from the whisker pads and TGs of C57BL/6, 4 dpi. Each symbol repre-
sents the mean titres from five mice per virus, ±SEM. c) Quantification of β-galactosidase-posi-
tive cells during latent infection of mouse TGs with SC16 BE8 and SC16CMVlacZΔLAT-GFP.
Each symbol represents the number of positive cells per ganglion and floating bars represent
the mean of these data.
(TIF)
S5 Fig. LAT-negative HSV-1 reactivates at an increased frequency relative to the parent
recombinant, SC16CMVCre. Cumulative reactivation observed from ex vivo cultures of neu-
rons latently infected with SC16CMVlacZΔLAT-GFP and parental virus, as assessed by CPE in
the MRC5 feeder layer. Fractions indicate the absolute number of reactivating neurons / total
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neurons cultured.
(TIF)
S1 Dataset. Spreadsheet of study data.
(XLSX)
S1 Methods. Materials and methods for supplementary qRT-PCR analyses.
(DOCX)
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